NON SMALL CELL LUNG CANCER STAGE IIIB
Clinical trials for NON SMALL CELL LUNG CANCER STAGE IIIB explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER STAGE IIIB trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study seeks best dose of alectinib for ALK-Positive lung cancer patients
Disease control Recruiting nowThis study is for people with advanced ALK-positive non-small cell lung cancer. It tests three different doses of the drug alectinib to find the safest and most effective level. The goal is to control the cancer and improve outcomes for patients in Mexico.
Matched conditions: NON SMALL CELL LUNG CANCER STAGE IIIB
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated Jun 17, 2026 18:49 UTC
-
New drug shrinks lung tumors before surgery in early trial
Disease control Recruiting nowThis study tests whether giving the drug trastuzumab deruxtecan before routine surgery can shrink tumors in people with a specific type of lung cancer (HER2-amplified or HER2-mutated non-small cell lung cancer). About 14 adults with stage II to IIIB lung cancer will receive the d…
Matched conditions: NON SMALL CELL LUNG CANCER STAGE IIIB
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC